4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-26-077564
Chief Executive Officer sold 102,225 shares at an average $20.02 ($2,046,205)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Santos da Silva Jorge · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-09 | Sale : show line 1 in the form 10b5-1 | −33,936 | $20.01 | $679,059 | 2,843,182 | D |
| 2026-07-10 | Sale : show line 2 in the form 10b5-1 | −68,289 | $20.02 | $1,367,146 | 2,774,893 | D |
| Open-market sales · 102,225 sh · avg $20.02 · $2,046,205 | ||||||
Loading xslF345X06/ownership.xml…